Chronic acne in young people may be more than just skin deep. Research suggests many develop mental health concerns alongside skin issues. Early diagnosis and support can help. Learn more about psychocutaneous disorders in children and adolescents.
SkinCareRadar tracks newly published skincare and dermatology research, then explains what the findings mean in plain language — with evidence labels, source links, and no hype.
Chronic acne in young people may be more than just skin deep. Research suggests many develop mental health concerns alongside skin issues. Early diagnosis and support can help. Learn more about psychocutaneous disorders in children and adolescents.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Skin Barrier DamagePublished: March 27, 2026
Seborrheic Dermatitis Shampoo May Help Balance Scalp Lipids
Researchers studied a shampoo for seborrheic dermatitis, a skin condition causing inflammation and excessive oil production. They used a new tool called SpiderMass to analyze the oil on the scalps of people with the condition. The study found that the shampoo may help balance the oil and reduce inflammation. However, more research is needed to confirm these findings.
Why it matters: Understanding how to balance scalp lipids may help improve skin health and reduce symptoms of seborrheic dermatitis.
A small study with 42 participants, using a specific shampoo product, and with a short duration of 10 weeks.
Small Human StudySmall or uncontrolled human study. Results are preliminary.HyperpigmentationPublished: March 27, 2026
Setmelanotide May Help Young Children with Rare Obesity Disorder
A small study suggests that setmelanotide, a medication for rare obesity disorders, may help reduce hyperphagia and improve motor skills in a 2-year-old child with leptin receptor deficiency. The child's body mass index (BMI) and food cravings also decreased after treatment. However, more research is needed to confirm these findings.
Why it matters: This study may provide insights into the treatment of rare obesity disorders, but its relevance to skincare is unclear.
This case report is based on a single patient, and the long-term effects of setmelanotide in young children are unknown. The study had a short duration of 23 months and involved a small sample size.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.AcnePublished: March 27, 2026
Psychocutaneous Disorders in Children and Adolescents: Research Review
Researchers reviewed studies on psychocutaneous disorders in kids and teens, which are conditions where mental health and skin problems overlap. They found that many young people with chronic skin issues also have mental health concerns, and that early diagnosis and treatment may help. However, there's still a lot to learn about these conditions.
Why it matters: Understanding psychocutaneous disorders may help skincare professionals and parents identify and support young people with these complex conditions.
The review included studies from 2000-2025, but noted that there's a lack of pediatric-specific data and validated assessment tools for younger populations.
Small Human StudySmall or uncontrolled human study. Results are preliminary.TretinoinAcnePublished: March 26, 2026
Isotretinoin Use in Pediatric Patients: Barriers to Access and Treatment Continuity
Researchers studied how pediatric patients with severe acne access and use isotretinoin, a treatment for acne. They found that many patients faced difficulties with scheduling, pharmacies, and financial issues, which may have led to gaps in treatment. Despite these challenges, most patients felt their treatment was successful.
Why it matters: This study highlights potential barriers to effective acne treatment in underserved populations, which may inform strategies to improve access to care.
This study had a small sample size of 42 pediatric patients and was conducted at a single urban safety-net hospital.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Published: March 26, 2026
Machine Learning Models for Chemical Hazard Identification in Skincare
Researchers studied how machine learning models can help identify potential hazards in chemicals used in skincare products. They reviewed over 2,300 scientific articles and found that many models are not usable, but some may be helpful in predicting risks. The models were mostly used for skin sensitization and endocrine disruption.
Why it matters: This research may help skincare companies and regulators make better-informed decisions about the safety of chemicals used in skincare products.
The study was based on a review of existing literature and did not involve any new experiments or human studies. The models reviewed were mostly in-vitro or animal-only, and their usability and accuracy are uncertain.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Published: March 25, 2026
Vasculopathic skin lesions may be a sign of rare autoimmune disease
Researchers studied a rare autoimmune disease called anti-MDA5 dermatomyositis, which can cause skin lesions and muscle weakness. They found that some patients may have skin lesions that are a sign of the disease, but are often overlooked. This disease can be difficult to diagnose and may lead to serious health problems if not treated early.
Why it matters: Understanding this disease may help doctors diagnose and treat it more effectively, which could improve patient outcomes.
This study is based on a single case, and more research is needed to confirm these findings.
SkinCareRadar is a public research monitor focused on skincare ingredients, routines, devices, and skin conditions and concerns. It translates dermatology and cosmetic science research into plain language for the general public.
Every finding is linked to its original source. Evidence stages are labeled clearly. We do not diagnose, recommend treatment, or give medical advice. We distinguish cosmetic improvement from medically significant outcomes.